Technology ❯ Biotechnology ❯ Drug Development
Therapeutics Phase 3 Trials Antivenom Research Antibody-Drug Conjugates Startups Male Contraceptive Research ADC Technology Regulatory Approval Antibody Treatments Organoid Applications
The Venrock-led financing positions NaPi2b-targeting TUB-040 for earlier-line studies ahead of an Oct. 19 data update.
